Long-term Outcomes of Fecal Microbiota Transplantation in Patients With Cirrhosis.
作者信息
Bajaj Jasmohan S, Fagan Andrew, Gavis Edith A, Kassam Zain, Sikaroodi Masoumeh, Gillevet Patrick M
机构信息
Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University and McGuire Veterans Affairs Medical Center, Richmond, Virginia.
Division of Gastroenterology, Hepatology, and Nutrition, Virginia Commonwealth University and McGuire Veterans Affairs Medical Center, Richmond, Virginia.
出版信息
Gastroenterology. 2019 May;156(6):1921-1923.e3. doi: 10.1053/j.gastro.2019.01.033. Epub 2019 Jan 18.
Abstract
摘要
相似文献
1
Long-term Outcomes of Fecal Microbiota Transplantation in Patients With Cirrhosis.肝硬化患者粪便微生物群移植的长期结果
Gastroenterology. 2019 May;156(6):1921-1923.e3. doi: 10.1053/j.gastro.2019.01.033. Epub 2019 Jan 18.
2
Updates on the pathophysiology and therapeutic targets for hepatic encephalopathy.肝性脑病的病理生理学和治疗靶点的最新研究进展。
Curr Opin Gastroenterol. 2019 May;35(3):145-154. doi: 10.1097/MOG.0000000000000527.
3
Sex is associated with differences in gut microbial composition and function in hepatic encephalopathy.性别与肝性脑病中肠道微生物组成和功能的差异有关。
J Hepatol. 2021 Jan;74(1):80-88. doi: 10.1016/j.jhep.2020.06.046. Epub 2020 Jul 15.
4
Long-Term Effect of Rifaximin with and without Lactulose on the Active Bacterial Assemblages in the Proximal Small Bowel and Faeces in Patients with Minimal Hepatic Encephalopathy.利福昔明联合或不联合乳果糖对轻微肝性脑病患者近端小肠和粪便中活性细菌群落的长期影响。
Dig Dis. 2019;37(2):161-169. doi: 10.1159/000494216. Epub 2018 Nov 14.
5
Update on the Therapeutic Management of Hepatic Encephalopathy.肝性脑病治疗管理的最新进展
Curr Gastroenterol Rep. 2018 Apr 11;20(5):21. doi: 10.1007/s11894-018-0627-8.
6
Interaction of bacterial metagenome and virome in patients with cirrhosis and hepatic encephalopathy.肝硬化和肝性脑病患者的细菌宏基因组和病毒组的相互作用。
Gut. 2021 Jun;70(6):1162-1173. doi: 10.1136/gutjnl-2020-322470. Epub 2020 Sep 30.
7
Cost-Effectiveness of Rifaximin Treatment in Patients with Hepatic Encephalopathy.利福昔明治疗肝性脑病患者的成本效益分析。
J Manag Care Spec Pharm. 2020 Jun;26(6):750-757. doi: 10.18553/jmcp.2020.26.6.750.
8
Lactulose improves cognition, quality of life, and gut microbiota in minimal hepatic encephalopathy: A multicenter, randomized controlled trial.乳果糖可改善轻微型肝性脑病患者的认知功能、生活质量和肠道菌群：一项多中心、随机对照试验。
J Dig Dis. 2019 Oct;20(10):547-556. doi: 10.1111/1751-2980.12816.
9
Linkage of gut microbiome with cognition in hepatic encephalopathy.肝性脑病中肠道微生物组与认知的关联。
Am J Physiol Gastrointest Liver Physiol. 2012 Jan 1;302(1):G168-75. doi: 10.1152/ajpgi.00190.2011. Epub 2011 Sep 22.
10
Chronic Rifaximin Use in Cirrhotic Patients Is Associated with Decreased Rate of C. difficile Infection.肝硬化患者长期使用利福昔明与艰难梭菌感染率降低相关。
Dig Dis Sci. 2020 Feb;65(2):632-638. doi: 10.1007/s10620-019-05804-2. Epub 2019 Aug 22.
引用本文的文献
1
Toxins to treatments: Impact of environmental pollutants, gut microbiota, and natural compounds on non-alcoholic fatty liver disease progression.从毒素到治疗：环境污染物、肠道微生物群和天然化合物对非酒精性脂肪性肝病进展的影响
World J Hepatol. 2025 Aug 27;17(8):108772. doi: 10.4254/wjh.v17.i8.108772.
2
Fecal microbiota transplantation: A promising treatment strategy for chronic liver disease.粪便微生物群移植：一种治疗慢性肝病的有前景的策略。
World J Gastroenterol. 2025 Jul 28;31(28):105089. doi: 10.3748/wjg.v31.i28.105089.
3
Exploring the effects of faecal microbiota transplantation on cognitive function: A review of clinical trials.探索粪便微生物群移植对认知功能的影响：临床试验综述
Brain Behav Immun Health. 2025 Jul 4;48:101049. doi: 10.1016/j.bbih.2025.101049. eCollection 2025 Oct.
4
Fecal Butyrate and Deoxycholic Acid Concentrations Correlate With Mortality in Patients With Liver Disease.粪便中丁酸盐和脱氧胆酸的浓度与肝病患者的死亡率相关。
Gastro Hep Adv. 2025 May 9;4(8):100695. doi: 10.1016/j.gastha.2025.100695. eCollection 2025.
5
A special type of liver failure after partial hepatectomy: a case report.肝部分切除术后一种特殊类型的肝衰竭：病例报告
Front Oncol. 2025 Jun 2;15:1590035. doi: 10.3389/fonc.2025.1590035. eCollection 2025.
6
Microbial Approaches to Treat and Prevent Hepatic Encephalopathy.治疗和预防肝性脑病的微生物学方法
Gastroenterol Clin North Am. 2025 Jun;54(2):429-451. doi: 10.1016/j.gtc.2024.12.006. Epub 2025 Jan 23.
7
Key Insights into Gut Alterations in Metabolic Syndrome.代谢综合征中肠道改变的关键见解
J Clin Med. 2025 Apr 14;14(8):2678. doi: 10.3390/jcm14082678.
8
Hepatic encephalopathy treatment after transjugular intrahepatic portosystemic shunt: a new perspective on the gut microbiota.经颈静脉肝内门体分流术后肝性脑病的治疗：肠道微生物群的新视角
Front Med (Lausanne). 2025 Mar 7;12:1423780. doi: 10.3389/fmed.2025.1423780. eCollection 2025.
9
Multiple Concomitant Precipitating Factors of Hepatic Encephalopathy Are Associated With a Poor Prognosis in Patients With Cirrhosis Admitted to Intensive Care Unit.肝性脑病的多种并发促发因素与入住重症监护病房的肝硬化患者的不良预后相关。
United European Gastroenterol J. 2025 Jun;13(5):738-749. doi: 10.1002/ueg2.12706. Epub 2025 Mar 11.
10
Gut-X axis.肠-X轴
Imeta. 2025 Feb 26;4(1):e270. doi: 10.1002/imt2.270. eCollection 2025 Feb.
本文引用的文献
1
Preparing the Gut with Antibiotics Enhances Gut Microbiota Reprogramming Efficiency by Promoting Xenomicrobiota Colonization.用抗生素预处理肠道可通过促进外源微生物群定殖提高肠道微生物群重编程效率。
Front Microbiol. 2017 Jun 28;8:1208. doi: 10.3389/fmicb.2017.01208. eCollection 2017.
2
Changes in microbial ecology after fecal microbiota transplantation for recurrent C. difficile infection affected by underlying inflammatory bowel disease.艰难梭菌感染复发患者行粪菌移植后微生物生态学的变化受潜在炎症性肠病的影响。
Microbiome. 2017 May 15;5(1):55. doi: 10.1186/s40168-017-0269-3.
3
Healthy Donor Fecal Microbiota Transplantation in Steroid-Ineligible Severe Alcoholic Hepatitis: A Pilot Study.健康供体粪便微生物群移植治疗不适合使用类固醇的严重酒精性肝炎：一项试点研究。
Clin Gastroenterol Hepatol. 2017 Apr;15(4):600-602. doi: 10.1016/j.cgh.2016.10.029. Epub 2016 Nov 2.
4
Fecal microbiota transplantation in the management of hepatic encephalopathy.粪便微生物群移植在肝性脑病管理中的应用
Hepatology. 2016 Jan;63(1):339-40. doi: 10.1002/hep.28121. Epub 2015 Oct 1.
5
Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook.2015年粪便微生物群移植最新进展：适应证、方法、机制及展望
Gastroenterology. 2015 Jul;149(1):223-37. doi: 10.1053/j.gastro.2015.05.008. Epub 2015 May 15.
6
Covert hepatic encephalopathy is independently associated with poor survival and increased risk of hospitalization.隐匿性肝性脑病与较差的生存率和增加的住院风险独立相关。
Am J Gastroenterol. 2014 Nov;109(11):1757-63. doi: 10.1038/ajg.2014.264. Epub 2014 Sep 2.
7
Hepatic encephalopathy in chronic liver disease: 2014 Practice Guideline by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver.慢性肝病中的肝性脑病：美国肝病研究协会和欧洲肝脏研究协会2014年实践指南
Hepatology. 2014 Aug;60(2):715-35. doi: 10.1002/hep.27210. Epub 2014 Jul 8.
Zotero 插件